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Abstract
Background: The Swiss staging model for hypothermia uses clinical indicators to stage hypothermia and guide the
management of hypothermic patients. The proposed temperature range for clinical stage 1 is < 35–32 °C, for stage 2 is
< 32–28 °C, for stage 3 is < 28–24 °C, and for stage 4 is below 24 °C. Our previous study using 183 case reports from the
literature showed that the measured temperature only corresponded to the clinical stage in the Swiss staging model in
approximately 50% of cases. This study, however, included few patients with moderate hypothermia. We aimed to
expand this database by adding cases of hypothermic patients admitted to hospital to perform a more comprehensive
evaluation of the staging model.
Methods: We retrospectively included patients aged ≥18 y admitted to hospital between 1.1.1994 and 15.7.2016 with
a core temperature below 35 °C. We added the cases identified through our previously published literature review to
estimate the percentage of those patients who were correctly classified and compare the theoretical with the observed
temperature ranges for each clinical stage.
Results: We included 305 cases (122 patients from the hospital sampling and the 183 previously published). Using the
theoretically derived temperature ranges for clinical stages resulted in 185/305 (61%) patients being assigned to
the correct temperature range. Temperature was overestimated using the clinical stage in 55/305 cases (18%)
and underestimated in 65/305 cases (21%); important overlaps in temperature existed among the four stage
groups. The optimal temperature thresholds for discriminating between the four stages (32.1 °C, 27.5 °C, and
24.1 °C) were close to those proposed historically (32 °C, 28 °C, and 24 °C).
Conclusions: Our results provide further evidence of the relationship between the clinical state of patients and
their temperature. The historical proposed temperature thresholds were almost optimal for discriminating between the
different stages. Adding overlapping temperature ranges for each clinical stage might help clinicians to make appropriate
decisions when using clinical signs to infer temperature. An update of the Swiss staging model for hypothermia including
our methodology and findings could positively impact clinical care and future research.
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Background
The “Swiss staging classification” uses clinical informa-
tion to stage the severity of hypothermia (Table 1) and
was first published as part of a recommendation on the
medical treatment of hypothermia published by the
International Commission for Alpine Rescue [1]. This
classification is widely used and integrated in the inter-
national management guidelines on accidental hypothermia
[2, 3]. However, the evidence level sustaining the correl-
ation between a proposed range of body temperatures and
the clinical state of the patient is low. We previously pub-
lished an evaluation based on out-of-hospital cases
published in the medical literature [4]. We showed that the
measured core body temperature only corresponded to the
clinical stage in the Swiss staging model of hypothermia in
approximately 50% of cases [4]. Globally, the core
temperature of patients was lower than those proposed by
the Swiss staging model according to the clinical stage of
the patient [4]. One important limitation we acknowledged
was the potentially important risk of publication bias [4].
Furthermore, there was a relative paucity of moderately
hypothermic cases. We aimed to complete this database by
adding cases of hypothermic patients admitted to hospital
with the aim of performing a more comprehensive evalu-
ation of the Swiss staging model for hypothermia.
Methods
The design and methodology were very similar to those
we previously described in the princeps study [4]. We
retrospectively included patients aged ≥18 y admitted to
one of the two Swiss hospital included (Lausanne and
Sion, Switzerland) between 1.1.1994 and 15.7.2016 with
a core temperature below 35 °C. These hospitals were
selected as they share a joint ethics committee, and as
their respective emergency departments regularly collab-
orate in research projects. We excluded patients for
which data on clinical parameters and vital signs at pres-
entation did not allow a classification using the Swiss
staging model. To ensure that any impairment in con-
sciousness could be firmly attributed to hypothermia
alone, we excluded cases with any mention or suspicion
of one of the following potential confounding factors:
acute alcohol or other intoxication, drug overdose,
hypoglycemia < 3 mmol/L, traumatic brain injury, or
medical conditions that could lead to hypothermia.
Cases of therapeutic and neonatal hypothermia were
also excluded. A blood alcohol concentration of up to
150 mg/dL was not grounds for exclusion as this is
considered the threshold at which signs of altered
consciousness might occur [5]. The screening and in-
clusion was performed by one of the authors (AR),
who accessed the patient’s medical chart. Questions
were resolved by discussion with one of the other au-
thors (MP). When in doubt, cases were not included
in the database. The data collected from the included
cases were entered in a spreadsheet (Excel; Microsoft,
Redmond, WA, USA) that was then coded.
The following data were collected: age, sex, vital
parameters, first recorded core body temperature, pres-
ence of shivering, occurrence of cardiac arrhythmia,
causes of accidental hypothermia (the mechanism for
hypothermia: immersion, exposure submersion, ava-
lanche with burial of head under the snow), rewarming
method, hospital survival, and neurological outcome
(CPC: cerebral performance categories 1 = normal or
slightly diminished cerebral function, 2 = moderate cere-
bral disability, 3 = severe cerebral disability, 4 = coma or
vegetative state, and 5 = brain dead) [6]. Consciousness
was evaluated using the Glasgow Coma Scale (GCS), the
Alert-Verbal-Pain-Unresponsive (AVPU) classification,
or any other descriptive clinical information available.
Since we noticed in our initial study that the presence or
absence of shivering was very seldom documented [4], we
decided to clinically stage hypothermia solely on the basis
of state of consciousness and vital signs. Information on
shivering, when available was, however, collected. Cases
were clinically classified as follows: stage 1 was defined as
a GCS score = 15 or ‘A’ from the AVPU classification; stage
2 as a GCS score > 8 and < 15 or ‘V’ from AVPU; stage 3
as a GCS < 9 or ‘P’ or ‘U’ from AVPU; stage 4 as the
absence of vital signs (respiratory rate of 0, no measurable
blood pressure, no palpable pulse) and GCS = 3 or ‘U’
from AVPU [7, 8]. The study was approved by the institu-
tional ethics committee (CER-VD 2016–01267).
Statistical analysis
The cases identified through our previously published
literature review (“literature sampling”) [4] were added
to the included case of the present study (“hospital sam-
pling”) to constitute the database. Descriptive statistics
were determined for variables of interest and were
expressed as frequencies, means and standard deviations,
Table 1 Swiss clinical staging of hypothermia
Brown et al.,
2012 (2)
Durrer et al.,
2003 (1)
Typical core
temperature
(°C)
Stage 1 Conscious, shivering Clear consciousness
with shivering
35 to 32
Stage 2 Impaired consciousness,
not shivering
Impaired consciousness
without shivering
< 32 to 28
Stage 3 Unconscious, not
shivering, vital
signs present
Unconsciousness < 28 to 24
Stage 4 No vital signs Apparent death < 24
There are minor differences between the original system developed by Durrer
et al. [1] and the most recent versions [2]. Each clinical stage is associated with
an estimate of core body temperature
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or medians and interquartile range (IQR) depending on
the nature of the variables (categorical, normally distrib-
uted, quantitative but not normally distributed). Com-
parisons were conducted using Pearson’s Chi-square or
Fischer’s exact tests, Student’s t-test, or the Wilcoxon
rank-sum test accordingly. A bilateral p-value < 0.05 was
considered to indicate a significant difference between
patient groups. Three receiver operating characteristic
(ROC) analyses were performed to determine the opti-
mal temperature thresholds for discriminating between
the four clinical stage groups. For every possible thresh-
old temperature, t sensitivity was defined as the propor-
tion of patients in the higher stage group with a
temperature below t, and specificity as the proportion of
patients in the lower stage group with a temperature
equal to or higher than t. We used the area under the
ROC curve (AUC) to summarise the discrimination
between two groups. The optimal temperature to
discriminate two groups was defined as the threshold t
which maximises the sum of sensitivity plus specificity,
which is equivalent to the Youden index [9]. Data was
retrieved from the patient information database and
exported into Stata version 14 (Stata Corporation,
College Station, TX, USA) for analysis.
Results
We included 122 patients from our hospital sampling
(Fig. 1). Addition of the 183 previously published cases
identified through our literature review [4] resulted in a
database of 305 cases for analysis. Most (84%) of the hos-
pital patients were in clinical stage 1 or 2, and most (81%)
cases from the literature sampling were classified as stages
3 or 4 (Table 2). Shivering was mentioned only 19 times in
the medical charts of hospital patients (reported as
present in 14 and absent in 5 patients). Among the
patients with shivering, six were in clinical stage 1, five in
stage 2, and three in stage 3. Their median temperature
was 30.5 °C (IQR 29–32.2; range 21–34).
The correspondence between clinical stage and the
measured temperature for the 305 cases is presented in
Table 3. The observed mean temperature was 33.2 ±
1.6 °C for patients clinically classified as stage 1, 29.4 ±
3.0 °C for those classified as stage 2, 26.0 ± 3.4 °C for
stage 3, and 22.8 ± 4.3 °C for stage 4.
The percentage of patients who were correctly classi-
fied by the Swiss clinical staging (i.e. whose temperature
was in the range predicted by their clinical stage) was
61% (185/305, 95% CI = (55 –66%)) overall and was
significantly higher (p < 0.001) in the hospital sampling
Fig. 1 Flowchart of study cases
Pasquier et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine           (2019) 27:60 Page 3 of 8
(74%; 90/122) than the literature sampling (52%, 95/183)
. Overall, temperature was overestimated using the clin-
ical stage to predict temperature in 55/305 cases (18%),
and underestimated in 65/305 cases (21%).
The results of the ROC analyses are shown in Fig. 2.
The optimal temperature threshold for discriminating
between stage 1 and stage 2 is 32.1 °C (actual cutoff =
32 °C), between stages 2 and 3 is 27.5 °C (actual
cutoff = 28 °C), and between stages 3 and 4 is 24.1 °C
(actual cutoff = 24 °C).
Discussion
In this retrospective study of 305 cases of hypothermic
patients identified through literature and hospital chart
reviews, only 61% of patients had a temperature in the
range predicted by their clinical stage. However, we
found that the historical [1] proposed temperature
thresholds (i.e. 32 °C, 28 °C, and 24 °C) were almost opti-
mal for discriminating between the different stages. Our
study findings could positively influence clinical care
practices, notably regarding the on-site management of
potentially hypothermic patients.
Rate of correct classification and consequences of
misclassifications
Our results provide further evidence of the performance
of the Swiss staging model, in particular the rate of
incorrect classifications. Using the theoretically derived
temperature ranges for clinical stages would result in ap-
proximately 40% of patients being assigned to a wrong
temperature range. The potential clinical consequences
of such misclassifications have been extensively dis-
cussed in our first study [4]. Underestimating the
patient’s temperature (which would have been the case
for 21% of our patients) might lead to unnecessary pa-
tient monitoring or to incorrect hospital orientation, but
probably not to any deleterious consequences apart from
a waste of resources. Overestimating the temperature of
the patient when using the clinical stage (which would
have been the case for 18% of our patients) is more
concerning. It might lead to under-treatment of the pa-
tient due to an underestimation of the risk of cardiac
arrest (CA) in clinical stage 1 patients with an actual
temperature < 30 °C [10], to sub-optimal patient orienta-
tion in clinical stage 2 patients with an actual
Table 2 Comparison of baseline characteristics between the cases identified through hospital sampling and those identified from
the literature review
Overall (n = 305) Hospital (n = 122) Literature (n = 183) P value
Age (years), mean ± SD 47 ± 26 56 ± 22 41 ± 27 < 0.001
Sex male, n (%) 186 (61) 75 (61) 111 (61) 0.886
Temp (°C), mean ± SD 27.7 ± 5.2 31.8 ± 3.3 25.0 ± 4.4 < 0.001
GCS, median (IQR) 7 (3–15) 15 (12–15) 3 (3–6) < 0.001
Heart rate, mean ± SD 48 ± 39 71 ± 26 30 ± 37 < 0.001
Heart rate, median (IQR) 54 (0–80) 76 (58–90) 18 (0–54) < 0.001
Systolic blood pressure (mmHg), mean ± SD 121 ± 31 131 ± 25 101 ± 33 < 0.001
Respiration rate, median (IQR) 0 (0–16) 18 (10–20) 0 (0–0) < 0.001
Clinical stage, n (%) < 0.001
1 89 (29) 79 (65) 10 (5)
2 47 (15) 23 (19) 24 (13)
3 79 (26) 12 (10) 68 (37)
4 90 (30) 8 (7) 81 (44)
Cause, n (%) < 0.001
Water exposition 91 (30) 14 (11) 77 (42)
Avalanche 17 (6) 9 (7) 8 (4)
Environmental/other/unknown 197 (65) 99 (81) 98 (54)
Survival, n (%) 262 (94) 112 (92) 150 (96) 0.195
Outcome for survivors, n (%) 0.060
CPC 1 251 (96) 111 (99) 140 (93)
CPC 2–3 6 (2.3) 1 (0.9) 5 (3.3)
Unknown 5 (1.9) 0 (0) 5 (3.3)
CPC cerebral performance categories (1 = normal or slightly diminished cerebral function, 5 = brain dead); GCS Glasgow Coma Scale, IQR interquartile range
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temperature < 28 °C [2, 11], or to an underestimation of
the magnitude of the risk of cardiac arrest in clinical
stage 3 patients with an actual temperature < 24 °C [12].
Importance of the Swiss staging model
Having a reliable measurement or estimate of a patient’s
core temperature is important since some critical
decisions are based on the temperature value [13, 14].
This is notably the case regarding the withholding of de-
fibrillation after an initial three shocks in a CA patient
with a temperature < 30 °C [3], the interruption in chest
compressions in some selected CA patients with a
temperature < 28 °C [3, 15], or the transport of non-
arrested patients with a temperature < 28 °C directly to an
ECLS (Extracorporeal Life Support) centre [2, 3, 11].
Temperature is also used to evaluate the risk of cardiac ar-
rest which might occur below 30 °C [10] as well as its mag-
nitude, which increases as temperature decreases [2, 11].
Despite the well-established and acknowledged im-
portance of temperature to guide the management of
potentially hypothermic patients, it has been shown
in many different setting and countries that suitable
thermometers, notably low-reading thermometers, are
often lacking [13, 14, 16–20]. Obtaining an accurate
temperature measurement in the prehospital setting is
also subject to some limits, including in conscious pa-
tients [19, 21, 22]. The research and development of
new adapted thermometers is ongoing and might pro-
vide a solution in the future [14]. However, even if it
did exist, an appropriate thermometer might not
always be available, and having a clinically based esti-
mation of core temperature is thus important.
This lack of suitable tools explains why the Swiss
staging model is widely used in clinical (notably prehos-
pital) practice, as reflected by its mention in the major
guidelines on hypothermia management [2, 3, 11, 23].
The Swiss staging model may be used by medical as well
as non-medical care providers when an accurate core
temperature measurement is not possible or available
[19]. Several rescue teams are indeed not equipped with
any thermometers and instead use the Swiss staging
model [18]. For all these reasons, increasing the evidence
level sustaining the link between the clinical state of a
given patient and his/her core temperature estimation is
of utmost importance.
Practical implications of our findings and the proposal of
improvements to the Swiss staging model
Our estimates of the optimal thresholds to discriminate
between the different stages were remarkably close to
those proposed for the original Swiss staging model
(32.1 °C vs 32 °C for stage 1 and 2 groups, 27.5 °C vs.
28 °C for stage 2 and 3 groups, and 24.1 °C vs 24 °C for
stage 3 and 4 groups) [1]. This study provides further
Table 3 Correspondence between the clinical stage and the measured temperature for the 305 cases
≥ 32 T° < 35 ≥ 28 T° < 32 ≥ 24 T° < 28 T° < 24 overall, N (%) mean T ± SDa range 95% CI for mean 90% prediction intervalb
Stage 1, n (%)
Hospital 66 13 0 0 79 (64.8) 33.4 ± 1.3 28.5–34.9 33.1–33.7 30.8–34.6
Literature 4 6 0 0 10 (5.5) 31.3 ± 2.2 28.1–34.2 29.7–32.9 28.3–34.1
Overall 70 19 0 0 89 (29.2) 33.2 ± 1.6 28.1–34.9 32.8–33.5 30.0–34.6
Stage 2, n (%)
Hospital 4 15 3 1 23 (18.9) 30.6 ± 2.5 26.0–34.8 29.5–31.6 26.1–34.0
Literature 3 11 8 2 24 (13.1) 28.3 ± 3.2 22.0–34 27.0–29.6 23.3–33.9
Overall 7 26 11 3 47 (15.4) 29.4 ± 3.0 22.0–34.8 28.5–30.3 24.8–34.0
Stage 3, n (%)
Hospital 1 5 4 2 12 (9.8) 28.1 ± 3.9 19.8–33.5 25.7–30.6 22.7–32.3
Literature 3 12 33 20 68 (37.2) 25.6 ± 3.2 19.3–33.4 24.9–26.4 21.0–31.6
Overall 4 17 37 22 80 (26.2) 26.0 ± 3.4 19.3–33.5 25.3–26.8 21.0–31.9
Stage 4, n (%)
Hospital 0 1 2 5 8 (6.6) 24.5 ± 2.8 20.2–28 22.1–26.9 20.8–27.9
Literature 0 9 25 47 81 (44.3) 22.7 ± 4.3 13.7–31.8 21.7–23.6 15.5–28.9
Overall 0 10 27 52 89 (29.2) 22.8 ± 4.3 13.7–31.8 22.0–23.7 15.7–28.9
a In nine cases, we retained the lowest temperature of the thermometer as the actual temperature; p < 0.05 for T° between hospital and literature for stages 1, 2,
and 3 (but not for stage 4)
b 90% prediction intervals were calculated using quantiles 5 and 95%, such that the probabilities that the temperature of an individual is found either below or
above that range are both equal to 5%
T° = core body temperature in °C
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Fig. 2 ROC curves and optimal core body temperature thresholds in °C for stage discrimination. For every possible threshold temperature, T°, sensitivity
was defined as the proportion of patients in the higher stage group with a temperature below T°, and specificity as the proportion of patients in the
lower stage group with a temperature equal to or above T°. The temperature that best distinguished between stages was taken as the temperature
value that maximised the sum of sensitivity plus specificity. Using the estimated optimal thresholds increased (sensitivity + specificity) from 160 to 161
for the stage 1/2 threshold, from 146 to 147 for the stage 2/3 threshold, and from 131 to 135 for the Stage 3/4 threshold. Actual cut = accepted
threshold for current clinical Swiss staging system; optimal cut = optimal threshold i.e. the temperature at which the sum of sensitivity + specificity is
maximal; AUC = area under the curve
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evidence to support these figures. However, this study
including additional data from hospital cases also
confirms the important overlaps between the four stage
groups with respect to core temperature [4]. This
strengthens the idea that it might be preferable to asso-
ciate the different stages with overlapping temperature
ranges. One could typically use prediction intervals
(e.g. 90%), which based on our study, would be ≥30 °C
for stage 1, 25–34 °C for stage 2, 21–32 °C for stage 3,
and ≤ 29 °C for stage 4.
Since it is recommended that treatment should be
guided based mainly on some key clinical factors (e.g.
the level of consciousness or cardiovascular stability), it
is also recognised that the core temperature can provide
additional helpful information [23]. It is already known
that the core temperature does not always correspond to
a precise level of consciousness or clinical state [19]. It
has, however, been recently advocated that the correl-
ation of clinical stage with core temperature should be
better defined [12, 24]. It has also been suggested that
clinicians should be aware of the limits and pitfalls of
using clinical signs to infer core temperature [19]. The
Swiss staging model will still be used on many occasions
when accurate core temperature measurement is not
possible. Our study should help clinicians to guide their
management and decisions based on a more compre-
hensive estimation on the core temperature.
Limitations
Our study suffers from several limitations. First, we were
unable to include the presence or absence of shivering
in our analysis due to the paucity of cases for which this
information was available, not among the literature cases
[4], but also among the hospital charts. Shivering is
mentioned in the first stage of the original Swiss staging
model [1]. It has, however, been reported in patients
with deep hypothermia [25, 26]. Furthermore, it might
be misleading to use shivering additionally to the state
of consciousness, since patients could be classified in
two different stages depending on their clinical findings.
We would therefore advocate analysing the relationship
between shivering and temperature independently from
the state of consciousness to avoid confusion. A second
limitation is related to the reported body temperature of
the hypothermic patients that were included in this
study. We cannot be certain that effective devices were
used properly. The use of an inappropriate device or a
delay between measurement and the clinical evaluation
of the patient could potentially have biased our results.
However, we have no evidence to indicate that such a
bias, if any, would be systematic. Our convenience
sample of two hospitals may also be considered as a
limitation. Although this may theoretically limit the
external validity of our findings, we have no reason to
suppose that this may induce any systematic bias. Fi-
nally, we were not able to gather reliable information
on the clinical decision-making process, as well as the
relevant outcomes such as the presence or occurrence
or arrhythmias or hospital complications. This might
have provided interesting information about the clin-
ical consequences of potential misclassifications. Most
these limitations pertain to the retrospective nature of
the study. Additional prospective studies or the ana-
lysis of good-quality prospectively collected data
would be needed to overcome these limitations and
validate our findings.
Conclusions
Our results provide further evidence of the relationship
between the clinical state of hypothermia and the
measured temperature. We suggest to define the four
clinical stages using the definitions we used in this study,
which would also help to guiding future research.
Adding overlapping ranges of temperature for each
clinical stage might help clinicians to make appropriate
decisions when using clinical signs to infer core
temperature. A new version of the Swiss staging model
for hypothermia would be the next valuable step, which
should ideally be discussed and validated by the
International Commission for Alpine Rescue Alpine
Emergency Medicine Commission (ICAR-MEDCOM).
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